Health Care Technology

Veeva Systems -CL

Salesforce

Conference Minutes

INFA

VEEV

TWTR

08391

4502

Below is Dolphin Research's Trans of $Salesforce(CRM.US) FY26 Q4 earnings call.For our earnings analysis, cf. 'Salesforce: The AI replacement thesis sweeps the field — has the SaaS leader been cast aside?'Key takeaways recap1) Q1 guidance: revenue of $11.03–11.08bn, implying reported growth of ~12–13%.Management also guides Q1 CRPO to grow ~14% YoY on a reported basis ...

ServiceNow

Informatica

Sunrun

AstraZeneca PLC

AstraZeneca

Pfizer

Twitter

CORNERSTONE TEC

Takeda Pharmaceutical Co. Ltd.

CRM Trans: Organic rev. growth to re-accelerate in H2 FY

---

Veeva Systems Earns 'Moderate Buy' Consensus Recommendation from 26 Firms, Reports Exceeding Earnings Per Share

Veeva Reports 27% Net Income Growth to $909 Million in Fiscal Year 2026

Veeva Systems Acquires Ostro to Enhance AI-Driven Interactions

Veeva Systems Acquires Rise Healthcare Tech for $100 Million

Veeva Systems Announces $2 Billion Stock Buyback Program

Veeva Systems -CL released FY2026 Q4 earnings on March 4 After-Market (EST), actual revenue USD 835.95 M (forecast USD 810.95 M), actual EPS USD 1.45 (forecast USD 1.3164)

Veeva Systems -CL released FY2026 Annual Earnings on March 4 After-Market EST, actual revenue USD 3.195 B (forecast USD 3.171 B), actual EPS USD 5.44 (forecast USD 5.2843)

Veeva Systems Inc. Q4 and FY2026 Earnings Exceed Expectations

Veeva Systems Launches Veeva AI

Veeva Systems Inc. Launches eSource to Enhance Clinical Trial Data Management

Veeva Systems -CL to Release FY2026 Q4 Earnings on March 4 After-Market (EST), Forecast Revenue USD 810.95M, EPS USD 1.3164

Jensen Investment Management Inc. significantly increased its holdings in Veeva Systems Inc.

Veeva Systems launches Veeva eSource application

Veeva Systems CEO Reports Sale of Company's Common Stock

Veeva Systems showcases industry cloud strategy and AI innovation at JPM 2026 Healthcare Conference

Goldman Sachs Issues a Sell Rating on Veeva Systems

Peregrine Capital Management LLC Reduces Holdings in Veeva Systems Inc.

Veeva Systems Announces New Environmental Monitoring Solution

Novo Nordisk Chooses Veeva Vault CRM and Expands Partnership

Veeva Systems Announces Up to $2 Billion Share Repurchase Program

OPTIMI HEALTH CORP

HCW Biologics

Silexion Therapeutics

Vida Global

GCL Global

BiomX

MetaVia

Micware

MicroAlgo

Earning Release Date

财报预告

FY2027 Q1 Earning Release 2026.06.03 (EST) After-Market

Veeva Systems, Inc. (VEEV.US) Q4 and Full Year Earnings Call for Fiscal Year 2026

Veeva Systems, Inc. (VEEV.US) Fiscal Year 2026 Second Quarter Earnings Conference Call

Veeva Systems, Inc. (VEEV.US) Q1 Fiscal Year 2026 Earnings Conference Call

Veeva Systems, Inc. (VEEV.US) Q4 and Full Year Earnings Conference Call for Fiscal Year 2025

Veeva Systems, Inc. (VEEV.US) Q3 earnings conference call for fiscal year 2025

LABU

Accumulus Technologies and Smith+Nephew have made significant moves by integrating their operations with Veeva Systems, enhancing its role in life sciences. Smith+Nephew's adoption of Veeva Quality Cloud for quality management is particularly noteworthy. While these developments are positive for Veeva's investment narrative, the company faces risks related to customer adoption of new technologies. Analysts project Veeva's revenue could reach $4.6 billion by 2029, with a fair value estimate of $264.46, indicating potential upside.

Simplywall

Smith and Nephew

Invesco Biotechnology & Genome ETF

Direxion S&P Biotech Bull 3X

VanEck Biotech ETF

SPDR S&P Biotech

First Trust NYSE Arca Biotech Index Fd

Accumulus and Smith+Nephew Deals Could Be A Game Changer For Veeva Systems (VEEV)

Veeva Commercial Summit to Feature Biopharma's AI Successes and the Path to Agentic Commercial | VEEV Stock News

StockTitan

Veeva Commercial Summit to Feature Biopharma's AI Successes and the Path to Agentic Commercial | VEEV Stock News

Empire Life Investments Inc. increased its stake in Veeva Systems Inc. by 21.1% in Q4, acquiring an additional 6,453 shares, bringing its total to 37,054 shares valued at $8.27 million. Other hedge funds also increased their holdings in Veeva. The stock opened at $159.55, with a market cap of $26.06 billion and a P/E ratio of 29.49. Veeva reported a Q4 EPS of $2.06, exceeding estimates, and has set FY 2027 guidance at 8.850 EPS. Analysts have mixed ratings, with target prices ranging from $200 to $355.

Market Beat

UBS Group AG

Morgan Stanley

Piper Sandler Cos

Wells Fargo

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

Empire Life Investments Inc. Acquires 6,453 Shares of Veeva Systems Inc. $VEEV

Veeva Systems (NYSE:VEEV) has delivered an average annual return of 19.07% over the past decade, outperforming the market by 5.37%. With a current market capitalization of $25.89 billion, a $1000 investment in VEEV stock 10 years ago would now be worth $5,712.80, highlighting the significant impact of compounded returns on investment growth.

benzinga_article

Here's How Much You Would Have Made Owning Veeva Systems Stock In The Last 10 Years

Smith+Nephew is partnering with Veeva Systems to unify its quality management through Veeva Quality Cloud. This initiative aims to enhance compliance and operational efficiency by creating an integrated quality ecosystem. The platform will facilitate collaboration, automation, and data analytics, improving decision-making processes. Smith+Nephew will utilize Veeva QualityDocs for managing quality content and Veeva QMS for centralizing operations. This transformation is expected to support growth and innovation within the company.

Smith+Nephew Establishes Unified Quality Foundation Worldwide with Veeva Quality Cloud | VEEV Stock News

SBIO

Veeva Systems (VEEV) has seen a significant share price decline of 29.8% over the past year, currently priced at approximately $168.25. Despite a recent 7.9% gain in the past week, the stock has faced a 2.5% decline over the last month and a 23.3% drop year-to-date. A Discounted Cash Flow analysis suggests the stock is undervalued by 42.7%, estimating an intrinsic value of $293.79 per share. However, its P/E ratio of 30.23x is slightly above the fair ratio of 29.14x, indicating it may be overvalued compared to its tailored estimate.

Proshares Ultra Nasdaq Biotech

ALPS Medical Breakthrough

iShares Biotechnology ETF

Is It Time To Reassess Veeva Systems (VEEV) After A 29.8% One-Year Share Price Fall

Veeva Systems (NYSE:VEEV) has delivered an average annual return of 19.68% over the past decade, outperforming the market by 6.11%. With a current market capitalization of $26.97 billion, a $100 investment in VEEV stock 10 years ago would now be worth $602.01, reflecting the significant impact of compounded returns on investment growth.

$100 Invested In Veeva Systems 10 Years Ago Would Be Worth This Much Today

Veeva Systems -CL(VEEV.US)

Accumulus and Smith+Nephew Deals Could Be A Game Changer For Veeva Systems (VEEV)

Veeva Commercial Summit to Feature Biopharma's AI Successes and the Path to Agentic Commercial | VEEV Stock News

Empire Life Investments Inc. Acquires 6,453 Shares of Veeva Systems Inc. $VEEV

Here's How Much You Would Have Made Owning Veeva Systems Stock In The Last 10 Years

Smith+Nephew Establishes Unified Quality Foundation Worldwide with Veeva Quality Cloud | VEEV Stock News

Is It Time To Reassess Veeva Systems (VEEV) After A 29.8% One-Year Share Price Fall

$100 Invested In Veeva Systems 10 Years Ago Would Be Worth This Much Today

Trending